Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tony Gutschner

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 20, 2014
Silencing long noncoding RNAs with genome-editing toolsTony Gutschner
RNA Biology|January 11, 2023
RNA therapeuticsTony Gutschner
RNA Biology|June 6, 2012
The hallmarks of cancer: a long non-coding RNA point of viewTony Gutschner, Sven Diederichs
Cell Cycle (Georgetown, Tex.)|April 7, 2016
Genome engineering - Matching supply with demandTony Gutschner, Lynda Chin
International Journal of Molecular Sciences|January 13, 2015
Long non-coding RNAs in cancer and development: where do we go from here?Monika Haemmerle, Tony Gutschner
International Journal of Molecular Sciences|November 11, 2017
The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAsRoland Jacob, Sindy Zander, Tony Gutschner
Signal Transduction and Targeted Therapy|December 1, 2023
Going only half the way: cell cycle exit after the G1 restriction pointLisa Müller, Tony Gutschner, Mechthild Hatzfeld
Genome Research|August 17, 2011
Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleasesTony Gutschner, Marion Baas, Sven Diederichs
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 20, 2019
MALAT1: a therapeutic candidate for a broad spectrum of vascular and cardiorenal complicationsPrasanth Puthanveetil, Tony Gutschner, Johan Lorenzen
Journal of Molecular Medicine (Berlin, Germany)|March 27, 2013
MALAT1 -- a paradigm for long noncoding RNA function in cancerTony Gutschner, Monika Hämmerle, Sven Diederichs
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|November 20, 2014
Silencing long noncoding RNAs with genome-editing toolsTony Gutschner
RNA Biology|January 11, 2023
RNA therapeuticsTony Gutschner
RNA Biology|June 6, 2012
The hallmarks of cancer: a long non-coding RNA point of viewTony Gutschner, Sven Diederichs
Cell Cycle (Georgetown, Tex.)|April 7, 2016
Genome engineering - Matching supply with demandTony Gutschner, Lynda Chin
International Journal of Molecular Sciences|January 13, 2015
Long non-coding RNAs in cancer and development: where do we go from here?Monika Haemmerle, Tony Gutschner
International Journal of Molecular Sciences|November 11, 2017
The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAsRoland Jacob, Sindy Zander, Tony Gutschner
Signal Transduction and Targeted Therapy|December 1, 2023
Going only half the way: cell cycle exit after the G1 restriction pointLisa Müller, Tony Gutschner, Mechthild Hatzfeld
Genome Research|August 17, 2011
Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleasesTony Gutschner, Marion Baas, Sven Diederichs
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 20, 2019
MALAT1: a therapeutic candidate for a broad spectrum of vascular and cardiorenal complicationsPrasanth Puthanveetil, Tony Gutschner, Johan Lorenzen
Journal of Molecular Medicine (Berlin, Germany)|March 27, 2013
MALAT1 -- a paradigm for long noncoding RNA function in cancerTony Gutschner, Monika Hämmerle, Sven Diederichs
Pageof 5